Alzheimer’s Disease
Latest News in Alzheimer’s Disease
November 14, 2022
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
750 Active Alzheimer’s Disease Clinical Trials
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
BROWSE
FDA-approved DRUGS